Announced
Completed
Financials
Tags
Majority
Farming Fishing Ranching and Plantations
cannabis cultivation
Canada
Domestic
Merger
Acquisition
Single Bidder
Friendly
Public
Reverse Takeover
Completed
Synopsis
Aphria, an international producer and distributor of medicinal and recreational cannabis, completed the merger with Tilray, a pharmaceutical company that develops cannabis based medicines, drugs, drops, and oil products, in a $3.9bn deal. "Tilray is poised to strike and transform the industry with our highly scalable operational footprint, a curated portfolio of diverse medical and adult-use cannabis brands and products, a multi-continent distribution network, and a robust capital structure to fund our global expansion strategy and deliver sustained profitability and long-term value for our stakeholders," Irwin Simon, Aphria CEO. On April 15, 2021, Aphria's shareholders approved the proposed merger With Tilray.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.